Weifa ASA : Invitation to presentation of Weifa
Oslo, 21 August 2014
Weifa ASA (WEIFA.OL), Norway`s leading fully-integrated pharmaceutical company, is hosting a presentation of the company for investors, analysts, press and other interested parties, on 2 September at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway.
Following an introduction by the Chairman, Glen Rødland, the company will be presented by Kjell-Erik Nordby, CEO, and Gunnar Manum, CFO.
The presentation will start at 09:30, and last for approx. 1 hour.
Following the presentation, there will be a Q&A session.
No pre-registration required.
Weifa welcomes all interested parties.
For further information, please contact:
Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@aqualis.no
Weifa ASA (formerly Aqualis ASA) has, through the recent acquisition of Weifa AS, become Norway`s leading fully-integrated pharmaceutical company and a major supplier of active ingredients to the international pharmaceutical industry. Weifa currently employs about 180 highly qualified people, is headquartered in Oslo and has two manufacturing plants in Kragerø in southern Norway. Weifa`s Consumer Health business holds well-known Norwegian brands such as Paracet, Ibux and Paralgin Forte.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via GlobeNewswire
HUG#1850304
